Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study
Drug Design, Development and Therapy · 2025-11 · Volume 19 · 10269-10280
DOI: 10.2147/dddt.s558378 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Drug Design, Development and Therapy, 2025-11. Verfasst von Wenwei Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Acrylamides, Aminoquinolines, Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republ…
- Department of Medical Oncology, Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, 100122, People's Republic of China.
ORCID-Profile: Wenwei Yang
Zitieren
APA
Yang, W., Zhang, J., Wu, G., Zhang, W., Zhou, A., Yang, L., & Sun, Y. (2025). Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study. Drug Design, Development and Therapy, Volume 19, 10269-10280. https://doi.org/10.2147/dddt.s558378
Vancouver
Yang W, Zhang J, Wu G, Zhang W, Zhou A, Yang L, et al. Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study. Drug Design, Development and Therapy. 2025;Volume 19:10269-10280. doi:10.2147/dddt.s558378
BibTeX
@article{Yang2025,
author = {Yang, Wenwei and Zhang, Jing and Wu, Guifu and Zhang, Wen and Zhou, Aiping and Yang, Lin and Sun, Yongkun},
title = {Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {10269--10280},
doi = {10.2147/dddt.s558378}
}
EUVIMED